expanded label
FDA approves expanded label for Allergan’s Avycaz
June 24, 2016Medical Communications, Research and Development, Sales and Marketing Allergan, Avycaz, FDA, expanded label
Allergan (NYSE: FDA) has announced that the US Food and Drug Administration (FDA) has approved its supplemental new drug application …
Latest content
The evidence bar impacting UK medical cannabis access
November 6, 2026
Addressing the rheumatic disease diagnostic gap in primary care
November 5, 2026
